Aldesleukin Completed Phase 1 Trials for Renal Cancers / Drug Extravasation Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00004890Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer